Literature DB >> 6175616

Protoplast fusion permits high-frequency transfer of a Streptomyces determinant which mediates actinomycin synthesis.

K Ochi.   

Abstract

Prototrophic recombinants and heterocaryotic colonies developed at high frequency when protoplasts of nutritionally complementary actinomycin-producing and nonproducing strains of Streptomyces antibioticus were fused in the presence of polyethylene glycol and plated on minimal regeneration medium. Of the spores obtained from aerial hyphae of a single heterocaryotic colony, 99% carried the act+ character regardless of whether the nutritional markers of the spore were derived from the act+ or the act parent. Similarly, a high-frequency transfer (68% in S. antibioticus, 48% in Streptomyces parvulus) of act+ determinant(s) to act was achieved by protoplast fusion. Protoplasts of a doubly auxotrophic act strain of S. parvulus were efficiently transformed in the presence of polyethylene glycol with respect to the auxotrophic markers by DNA of an act+ auxotrophic strain with complementary nutritional requirements. The transformation frequency of the nutritional (chromosomal) markers was 17%. In contrast, the transformation frequency for actinomycin synthesis was less than 1%.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6175616      PMCID: PMC216405          DOI: 10.1128/jb.150.2.592-597.1982

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  21 in total

1.  Plasmid-determined antibiotic synthesis and resistance in Streptomyces coelicolor.

Authors:  R Kirby; L F Wright; D A Hopwood
Journal:  Nature       Date:  1975-03-20       Impact factor: 49.962

2.  Effects of ethidium bromide and acriflavine on streptomycin production by Streptomyces bikiniensis.

Authors:  P D Shaw; J Piwowarski
Journal:  J Antibiot (Tokyo)       Date:  1977-05       Impact factor: 2.649

3.  Action of acridine orange and ethidium bromide on growth and antibiotic activity of Streptomyces hygroscopicus JA 6599.

Authors:  R Kähler; D Noack
Journal:  Z Allg Mikrobiol       Date:  1974

4.  Biosynthetic precursors of etamycin, a peptidolactone antibiotic from Streptomyces griseoviridus.

Authors:  D J Hook; L C Vining
Journal:  Can J Biochem       Date:  1973-12

5.  Genetic recombination through protoplast fusion in Streptomyces.

Authors:  D A Hopwood; H M Wright; M J Bibb; S N Cohen
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

6.  Elimination of the ability of a kanamycin-producing strain to biosynthesize deoxystreptamine moiety by acriflavine.

Authors:  K Hotta; Y Okami; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1977-12       Impact factor: 2.649

7.  A plasmid involved in chloramphenicol production in Streptomyces venezuelae: evidence from genetic mapping.

Authors:  H Akagawa; M Okanishi; H Umezawa
Journal:  J Gen Microbiol       Date:  1975-10

8.  Biosynthesis of puromycin in Streptomyces alboniger: regulation and properties of O-demethylpuromycin O-methyltransferase.

Authors:  L Sankaran; B M Pogell
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

9.  Identification of the antibiotic determined by the SCP1 plasmid of Streptomyces coelicolor A3(2).

Authors:  L F Wright; D A Hopwood
Journal:  J Gen Microbiol       Date:  1976-07

10.  Development of a chemically defined medium for the synthesis of actinomycin D by Streptomyces parvulus.

Authors:  W K Williams; E Katz
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

View more
  2 in total

1.  Denaturation of circular or linear DNA facilitates targeted integrative transformation of Streptomyces coelicolor A3(2): possible relevance to other organisms.

Authors:  S H Oh; K F Chater
Journal:  J Bacteriol       Date:  1997-01       Impact factor: 3.490

2.  Structural analysis of plasmid and chromosomal loci involved in site-specific excision and integration of the SLP1 element of Streptomyces coelicolor.

Authors:  C A Omer; S N Cohen
Journal:  J Bacteriol       Date:  1986-06       Impact factor: 3.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.